Original Article
Post-chemotherapy liver atrophy does not impact the outcome after hepatectomy performed under a parenchymal-sparing approach
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:181-193
.
(01 April 2025)
PDF
Full Text
(529)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Preoperative chemotherapy for patients with colorectal liver metastases (CLM) could induce hepatic atrophy. A higher degree of atrophy does not impact on postoperative morbidity, hepatic insufficiency and death in patients with CLM when undergoing post-chemotherapy resection with a parenchymal sparing procedure.
Laparoscopic hepatectomy and near-infrared fluorescence based on the concept of “biliary territory” in the treatment of hepatolithiasis: a propensity score-matched study with videos
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:194-206
.
(01 April 2025)
PDF
Full Text (Video)
(726)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
The study introduced the innovative concept of 'biliary territory' for near-infrared fluorescence (NIF) guidance during laparoscopic hepatectomy. This approach demonstrated potential advantages in reducing perioperative complications and stone recurrence compared with traditional white light laparoscopy.
Short- and long-term outcomes of laparoscopic versus open resection of perihilar cholangiocarcinoma: a propensity score-based analysis
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:207-221
.
(01 April 2025)
PDF
Full Text
(527)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Some short-term and intraoperative outcomes of GBC patients after LR were better, but the long-term outcomes did not significantly differ between patients who underwent LR and those who underwent OR. The use of AC after curative-intent resection of GBC helped achieve better long-term survival outcomes.
Prevalence and longitudinal effects on mortality associated with spectrum of alcohol intake in steatotic liver disease: a United States population study
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:222-232
.
(01 April 2025)
The recently introduced terminologies MASLD, MetALD and ALD refer to different types of SLD associated with varying alcohol intake. They represent distinct conditions in terms of prevalence in the SLD population and mortality risks.
Endothelial glycocalyx damage marker syndecan-1 during hypothermic oxygenated machine perfusion of donor grafts facilitates prediction of early allograft dysfunction after liver transplantation
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:233-245
.
(01 April 2025)
PDF
Full Text
(513)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Endothelial glycocalyx is highly sensitive to IRI. Its main component Syndecan-1 (Sdc-1) was evaluated as biomarker at multiple time points during hypothermic oxygenated machine perfusion (HOPE) for liver transplantation. Sdc-1 at 60 minutes during HOPE allowed identification grafts with severe risk of early allograft dysfunction.
Expert Consensus
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition)
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:246-266
.
(01 April 2025)
Our consensus provides normative recommendations for the diagnosis, classification, prediction, and treatment of microvascular invasion(MVI) for the first time, which can better guide the treatment of MVI and improve the overall survival rate of hepatocellular carcinoma patients with MVI.
French Editorial Commentary from the ACHBPT
Surgical techniques and tumor dissemination: a critical review of the CETUPANC trial on the superior mesenteric artery vs. no-touch approaches
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:267-270
.
(01 April 2025)
Transplantation for colorectal liver metastases: lessons from TransMet and future challenges
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:271-274
.
(01 April 2025)
National impact and advantages of the robotic approach to liver surgery in the era of minimally invasive surgery
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:275-278
.
(01 April 2025)
Editorial Commentary
Intraoperative blood loss in perihilar cholangiocarcinoma: should we aim below a certain cut-off?
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:279-281
.
(01 April 2025)
New practice guidelines on risk stratification and management of portal hypertension: towards a personalized multidisciplinary approach
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:282-285
.
(01 April 2025)
Benchmark center volume and regional disparity in living donor liver transplantation
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:286-289
.
(01 April 2025)
Resmetirom as an important cornerstone of multidisciplinary management of metabolic dysfunction-associated steatohepatitis
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:290-294
.
(01 April 2025)
Graft-to-recipient weight ratio: a timeless standard still shaping outcomes
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:295-297
.
(01 April 2025)
Associations of the gut microbiome and metabolites on biliary tract cancer: insight from a bidirectional two-sample Mendelian randomization study
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:298-300
.
(01 April 2025)
Efficacy and challenges of combining transarterial chemoembolization with pembrolizumab in advanced hepatocellular carcinoma: insights from the PETAL study
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:301-304
.
(01 April 2025)
Recurrence beyond Milan criteria following liver resection for early-stage hepatocellular carcinoma: incidence, prediction and implications for treatment selection
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:305-307
.
(01 April 2025)
Recurrence after neoadjuvant therapy for pancreatic cancer: same challenges, new opportunities
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:308-310
.
(01 April 2025)
Advancing the management of hepatocellular carcinoma: surrogate markers and predictive biomarkers for survival on immunotherapy
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:311-315
.
(01 April 2025)
Shifting paradigm of quality of life after pancreatoduodenectomy for pancreas cancer
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:316-318
.
(01 April 2025)
High-volume living donor liver transplantation (LDLT): what the data tells us
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:319-321
.
(01 April 2025)
Innovations in liver organoids: the role of 3D bioprinting in creating functional organoids
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:322-325
.
(01 April 2025)
Sarcopenia’s increasingly vital role in liver cancer
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:326-328
.
(01 April 2025)
Editorial
Clinical advantages and efficacy of sleeve gastrectomy in the treatment of non-alcoholic fatty liver disease
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:329-331
.
(01 April 2025)
Advancing prognostic models in salvage liver transplantation
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:332-336
.
(01 April 2025)
A practical approach for the diagnosis and management of pancreatic cystic lesions—the Hong Kong consensus recommendations
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:337-341
.
(01 April 2025)
Anatomical or non-anatomical resections for hepatocellular carcinoma: a never-ending debate
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:342-344
.
(01 April 2025)
Guidelines for the management of pancreatic cystic lesions: many options, too few solutions?
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:345-347
.
(01 April 2025)
Letter to the Editor
Xalnesiran with or without an immunomodulator in chronic hepatitis B: still a challenge in functional cure
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:348-350
.
(01 April 2025)
Radiologic complete response after conversion therapy for hepatocellular carcinoma: is liver transplantation necessary?
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:351-354
.
(01 April 2025)
Images in Clinical Medicine
The first reported death of iNKLPD-GI: rethinking “watch and wait” strategy
HepatoBiliary Surgery and Nutrition
2025;
14
(2)
:355-357
.
(01 April 2025)
